表紙:世界の閉塞型睡眠時無呼吸症候群治療装置と睡眠診断機器市場規模、シェア、COVID-19の影響分析:2021~2027年:デバイスタイプ別(閉塞型睡眠時無呼吸症候群治療、睡眠診断装置)
市場調査レポート
商品コード
1028634

世界の閉塞型睡眠時無呼吸症候群治療装置と睡眠診断機器市場規模、シェア、COVID-19の影響分析:2021~2027年:デバイスタイプ別(閉塞型睡眠時無呼吸症候群治療、睡眠診断装置)

Sleep Apnea and Diagnostic Devices Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Includes: Sleep Management Devices by Type (Therapeutic Obstructive, Sleep Apnea, and Sleep Diagnostic Devices)

出版日: | 発行: iData Research Inc. | ページ情報: 英文 | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.50円

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

世界の閉塞型睡眠時無呼吸症候群治療装置と睡眠診断機器市場規模、シェア、COVID-19の影響分析:2021~2027年:デバイスタイプ別(閉塞型睡眠時無呼吸症候群治療、睡眠診断装置)
出版日: 2021年06月22日
発行: iData Research Inc.
ページ情報: 英文
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の閉塞型睡眠時無呼吸症候群治療装置および睡眠診断装置の市場規模は、予測期間中に拡大し、2027年にはそれぞれ49億米ドル、4億5,510万米ドルに達すると予測されています。

世界の閉塞型睡眠時無呼吸症候群治療装置市場のシェアは、ResMed、Philips Healthcare、Fisher &Paykelが占めています。同様に、世界の睡眠診断装置市場のリーダーは、Philips Healthcare、Natus、Compumedicsとなっています。

当レポートでは、世界の閉塞型睡眠時無呼吸症候群治療装置と睡眠診断機器市場について調査し、市場の概要とともに、2027年までの市場予測、市場成長の促進要因と抑制要因、および市場に参入する企業の競合情勢などを提供しています。

目次

  • 販売台数、平均販売価格、市場規模と成長動向
  • COVID-19の影響分析
  • 市場の促進要因と抑制要因
  • 2027年までの市場予測、および2017年までの実績データ
  • 最近の企業合併・買収状況
  • 企業プロファイルと製品ポートフォリオ
  • 主要な競合他社
目次
Product Code: iDATA_GLARS21_MC_SD

Throughout this medical market research, the publisher analyzed therapeutic obstructive sleep apnea device and sleep diagnostic device companies across more than 70 countries and used their comprehensive methodology to understand the Market Sizes, Unit Sold, Average Selling Prices, Company Market Shares, and to create Accurate Forecasts.

The global therapeutic obstructive sleep apnea device and sleep diagnostic device market sizes are estimated to increase over the forecast period to reach $4.9 billion and $455.1 million, respectively, by 2027.

The majority of the global therapeutic obstructive sleep apnea device market share was controlled by ResMed, Philips Healthcare, and Fisher & Paykel. Similarly, the global sleep diagnostic device market leaders were Philips Healthcare, Natus, and Compumedics.

This global market research spans over 70 countries and includes the global market for obstructive sleep apnea with the positive airway pressure device market and the sleep therapy interface market. In addition, the sleep diagnostic devices market is included with the polysomnography device market and the home respiratory polygraph device market.

MARKET DATA INCLUDED:

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

THERAPEUTIC OBSTRUCTIVE SLEEP APNEA DEVICE MARKET INSIGHTS

The primary driver for therapeutic obstructive sleep apnea devices in many markets is the growing awareness among the general population of sleep apnea symptoms and the benefits of its treatment. COVID-19 did not contribute to an increase in sleep-related conditions but, rather, sleep apnea therapy devices are less complex and easier to assemble than ventilators. In cases of severe COVID-19 where patients require acute care, and also in some home care applications, sleep therapy devices can be used in place of ventilators, contributing to a short-term rise in demand.

SLEEP DIAGNPOSTIC DEVICE MARKET INSIGHTS

The total sleep diagnostic device market is expected to grow steadily throughout the forecast period. Dictating a considerable price point are the polysomnography devices, which are by far the most sophisticated and accurate tests in the market. The ease of use and lower price point of home respiratory polygraphy devices will result in the market's notable future growth. In certain cases of COVID-19 where patients require acute care, and also in some home care applications, sleep apnea diagnostic devices can be used in place of ventilators, contributing to a short-term rise in demand.

Therapeutic Obstructive Sleep Apnea and Sleep Diagnostic Device MARKET SHARE INSIGHTS

ResMed, Philips Healthcare, and Fisher & Paykel controlled the global therapeutic obstructive sleep apnea device market share. The global sleep diagnostic device market was led by Philips Healthcare, Natus, and Compumedics.

In 2020, ResMed was the leading competitor in the therapeutic obstructive sleep apnea device market, with a notable presence in both the sleep therapy interface and PAP device segments. Philips Healthcare was the leading competitor in the sleep diagnostic device market, with a notable presence in both the polysomnography device and home respiratory polygraphy device segments.

RESEARCH REGIONAL COVERAGE

Throughout this report, iData Research has covered over 70 countries across the globe in great detail. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)